{"text": ["Pfizer", "Receives", "European", "Approval", "for", "Oncology", "Biosimilar,", "RUXIENCE\u2122", "(rituximab)"], "created_at": "2020-04-02 18:04:00"}
{"text": ["Pfizer", "Stock", "Rises", "3%"], "created_at": "2020-04-02 15:22:00"}
{"text": ["Susan", "Desmond-Hellmann", "Elected", "to", "Pfizer\u2019s", "Board", "of", "Directors"], "created_at": "2020-04-02 13:00:00"}
{"text": ["Thousands", "of", "U.S.", "Factories", "Can", "Be", "Retooled", "to", "Fight", "Coronavirus,", "According", "to", "a", "New", "Survey"], "created_at": "2020-04-02 12:00:00"}
{"text": ["EU", "will", "avoid", "medicine", "shortage,", "industry", "chief", "says"], "created_at": "2020-04-02 10:56:53"}
